skip to main |
skip to sidebar
Showing posts with label
pre-implantation genetic screening.
Show all posts
Showing posts with label
pre-implantation genetic screening.
Show all posts
Posted by
Administrator
at
6:00 AM
Labels:
ART,
Donor Egg,
embryo transfer,
ICSI,
IVF,
ovaries,
ovulation,
PESA,
PGD,
PGS,
pre-implantation genetic screening,
sperm,
TESA,
TESE
Found this on FertilityFriend.com:
I came across this in my wanderings, I know nothing about this clinic, but it is affordable, might make a good vacation with some fertility treatment added in: argentinafertilityservices.com
For Donor eggs
They guarantee 4 eggs for $4,300 US, and 8 for $5,500, and donor meds are included in that price
IVF (In Vitro Fertilization) is $3,000 but meds are not included
First office visit (one-time only): US $300
*no other charges for further office visits
Assisted Reproductive Techniques (ART) with own oocytes (IVF or ICSI): US $3,000
Assisted Reproductive Techniques (ART) with donor eggs (IVF or ICSI):
At least four (4) eggs: US $4,300
At least eight (8) eggs: US $5,500
Assisted Reproductive Techniques (ART) with donor sperm (IVF or ICSI): US $3,300
Included:
Donor medication for ovarian stimulation and egg production
Monitoring and procedures involved in management of both egg donor and recipient
Sperm freezing, if required
Medical and Institutional fees
Not included:
Medication for the IVF patient and the Egg Donor recipient
Surgeries prior to IVF treatment
Embryo cryopreservation
Sperm Retrieval Techniques:
TESE (Testicular Sperm Extraction)
TESA (Testicular Sperm Aspiration)
PESA (Percutaneous Epididymal Sperm Aspiration)
US $1,200
*sperm freezing for future attempts is included
Preimplantation Genetic Diagnosis (PGD):
US $2,200Source: http://www.fertilityfriend.com/Circles/viewtopic.php?t=1602041
Posted by
Administrator
at
6:00 AM
Labels:
Donor Egg,
Genes,
ICSI,
infertility,
IVF,
pre-implantation genetic screening
FAIRFAX, Va., July 25 /PRNewswire-USNewswire/ -- Genetics & IVF Institute announced today, on the 30th anniversary of the birth of the world's first IVF (in vitro fertilization) baby, that it has created more than 17,000 pregnancies through in vitro fertilization and other advanced techniques.
"Louise Brown, the world's first baby born through in vitro fertilization, was born in England on July 25, 1978, and media outlets trumpeted the news of the first 'test tube baby', says David Wise, president and CEO of Genetics & IVF Institute (GIVF), which is based in Fairfax, VA. "Now, people around the world are enjoying parenthood thanks to the invention of IVF by the remarkable British scientists Drs. Robert Edwards and Patrick Steptoe. We honor them today on the 30th anniversary of Louise Brown's birth."
Founded in 1984, GIVF was one of the first free-standing fertility
treatment centers in America. GIVF pioneered the development and
implementation of many improved fertility treatment technologies and methods, including non-surgical retrieval of eggs and sperm, intracytoplasmic sperm injection and pre-implantation genetic diagnosis of embryos (PGD). GIVF also developed a new, patented sperm separation technique for pre-conceptual gender selection called MicroSort (R) which is currently in an FDA clinical trial. It is the only American infertility treatment center with its own donor egg and donor sperm programs. GIVF also introduced high tech infertility treatment in China and is the only American center that provides infertility treatment in China.
Many of the pregnancies created at GIVF are in patients with particularly challenging infertility problems, including some who have been rejected for treatment by other centers.
"Every pregnancy is a cause for joy. Patients who come to GIVF seeking help to become pregnant are elated when they learn that they have achieved pregnancy and our staff is thrilled to help them," Mr. Wise said.
For more information on GIVF and its extraordinary range of programs, visit http://www.givf.com/ .
SOURCE: Genetics & IVF Institute
http://www.earthtimes.org/articles/show/washington-area-fertility-center-has-created-more-than-17000-pregnancies,481195.shtml
Recent Keyword Searches: what should you take to lower high estrogen level to get pregnant if your 40 years old, high fsh over 40, fertility in the 40s, is 40 too old for a baby, can you get a positive opk if your menopausal
Posted by
Administrator
at
6:00 AM
Labels:
aneuploidies,
FSH,
genomic imprinting abnormalities,
IVF,
pre-implantation genetic screening
Relationship between women's age and basal follicle-stimulating hormone levels with aneuploidy risk in in vitro fertilization treatment
Objective
To assess the relationship of age and basal FSH level to the genetic quality of the embryo and the association with IVF treatment outcome.
Patient(s)
One hundred fifty-one women who underwent IVF treatment cycles in conjunction with preimplantation genetic diagnosis for aneuploidy screening before fresh embryo transfer, between July 2003 and July 2005.
Intervention(s)
Basal FSH levels (days 2–4) were determined at an earlier cycle, and women were divided into two groups: high basal FSH (greater than or equal to 10 IU/L) and low basal FSH (less than 10 IU/L). Chromosome analysis was performed on a single blastomere by using fluorescence in situ hybridization.
Main Outcome Measure(s)
Percentage of aneuploid embryos.
Result(s)
The percentage of aneuploid embryos was not statistically significantly different between the high– (50.0%, n = 32) and low– (50.2%, n = 119) basal FSH groups. However, the percentage of aneuploid embryos was statistically significantly higher (56.2%, n = 109) for women aged greater than or equalto 38 years, as compared with women less than 38 years of age (37.5%, n = 42), independent of basal FSH levels.
Conclusion(s)
Elevated basal FSH levels reflect lower ovarian reserve but have no association with genetic quality of embryos. The percentage of aneuploid embryos is increased with advanced maternal age.
Source: http://www.fertstert.org/article/PIIS0015028207014185/abstract?rss=yes
Recent Keyword Searches: odds of getting pregnant for 41-year old, fibroid pregnancy age 40, tips for women in their 40's trying to conceive, fsh numbers and their meaning, having children in your 40's
Posted by
Administrator
at
6:00 AM
Labels:
Egg Freezing,
embryo,
infertility,
IVF,
pre-implantation genetic screening
Photo by clix
A fertility test that can double a woman's chances of pregnancy is being offered to childless couples for the first time.
The test identifies which eggs have the best chance of being successfully implanted in the womb - a major factor in determining the success of IVF treatment.
The test gives results in less than 48 hours, meaning the best eggs or embryos can be used immediately or frozen for future use.
Most existing tests take several days for their results to be processed.
Current tests also check for only a few abnormalities, whereas the latest technique - known as comparative genomic hybridisation - checks the egg has a full complement of normal chromosomes.
Specialists from the CARE Fertility Group of clinics said their pioneering technique could drastically improve the chances of pregnancy for women with long-standing fertility problems.
Results from a trial run with a team from the US found the number of embryos that implanted in the womb rose from 25 per cent to 50 per cent.
Dr Simon Fishel, managing director of the CARE Fertility Group, said the test used technology originally developed to detect cell abnormalities for cancer patients.
"We have been waiting for more than ten years for a technology which allows us to select the most viable embryos," he added.
"Until now it has not been possible to test eggs and embryos to evaluate all their chromosomes in an IVF cycle.
"We now have trial results showing CGH dramatically improves implantation rates because it allows us to choose eggs which are most likely to lead to a pregnancy.
"Since the trial started we have developed the test further and are ready to offer a novel array CGH to patients for the first time."
Doctors have been trying for some time to produce a test for pre-implantation genetic screening that is comprehensive and proven to improve conception rates.
Their efforts intensified after the British Fertility Society criticised earlier versions.
Last year CARE Fertility Group in Nottingham, in collaboration with the Sher Institutes for Reproductive Medicine in New York, tested DNA from a tiny part of the egg known as the polar body.
This contains all the chromosomes and can be safely removed without jeopardising its capacity to become an embryo.
Because the trial was using a prototype technique, the eggs were fertilised and frozen while the results were processed.
When the results came back, the best embryos were selected and implanted.
The results showed that 48 per cent of the selected embryos had successfully implanted - twice the expected rate.
Almost two-thirds of embryos transferred resulted in a delivery, leading to 26 out of 42 women having babies, including six sets of twins.
This rate was higher than the researchers had expected.
CARE's advanced version of the test is the first to be licensed by the IVF watchdog, the Human Fertilisation and Embryology Authority, for use in women over the age of 35 with a history of repeated IVF failures or recurrent miscarriage.
Dr Fishel hopes that eventually all women having IVF will be able to use the test to identify their eggs most likely to produce a baby.
This would mean they would not have to have two or three embryos implanted as an "insurance" policy.
He said: "This would help avoid the risk of multiple pregnancies because we could put back a single embryo with a high chance of success."
He admits the high cost of the technique - £2,900 for testing eight eggs - is likely to initially limit demand.
But he said that as more couples use the technique, which is available to private patients, the cost should come down.
IT'S LIKE WINNING THE LOTTERY
Childhood sweethearts Sam and Gareth Cornforth took part in the trial after years of fruitless IVF treatment.
Thanks to the test, the couple are today the proud parents of five-month-old twins George and Thomas.
Mr and Mrs Cornforth, who are both aged 35 and live near Derby, had been together since the age of 16 and had been trying for a child since they married in 2002.
Seemingly endless tests did not show why Mrs Cornforth could not become pregnant and IVF failed to work.
The couple saw a news item about CARE Fertility's trial and were among 1,700 who applied to take part in 2006.
"When we were chosen we felt this was our lotto ticket for a family of our own," said Mrs Cornforth, a travel agent.
It took eight weeks for the results of the test to be processed before the eggs could be used in treatment, six months after the trial began.
Six weeks later they found Mrs Cornforth was pregnant.
Mr Cornforth said: "On December 18 last year - my birthday - George and Thomas were born and it was the best present we could ever have."
Source: http://www.dailymail.co.uk/pages/live/articles/health/thehealthnews.html?in_article_id=565185&in_page_id=1797Recent Keyword Searches: can a women get pregnant when during menopause, can you get pregnant after 45., how to get pregnant @48, azithromycin infertility, soft ivf, pregnat at 48, taking aspirin while trying to get pregnant, can a 53 year old woman get pregnant, getting pregnanat at above 40, most realistic number of women over 40 who conceive naturally
Posted by
Administrator
at
6:40 AM
Labels:
aneuploidies,
chromosomal disorder,
embryo,
Fertility,
IVF,
multiple birth,
PGS,
pre-implantation genetic screening
Washington , Dec 31 (ANI): A revolutionary in vitro fertilisation (IVF) test, which may slash the risk of multiple births while increasing the chances of pregnancy, will soon be offered to British couples.
The pre-implantation genetic screening (PGS) test aims to boost the success rates when only a single embryo is transplanted into the womb, so that multiple pregnancies may be prevented.
However, a different form of PGS is already licensed to detect chromosomal abnormalities that cause embryos to fail, but only for older patients or those with a history of miscarriage or IVF failure.
The PGS test is also controversial with almost no proof to establish the fact that it aids in conception. It was recently reported that the British Fertility Society had recommended that its members stop using it.
In the more advanced version of PGS, around 50-100 women will be recruited. It will be conducted by Dagan Wells, of the Reprogenetics UK clinic and the University of Oxford .
Wells is seeking permission from the fertility regulator for the test, with a view to identifying the best embryo produced by young IVF patients aged under 35 having good prognosis.
If successful, the trial may influence many more infertile couples into opting for single embryos, corresponding to the Human Fertilisation and Embryology Authority's strategy to cut IVF twin and triplet births from one in four to one in ten.
At present, almost 90 per cent of IVF cycles use two embryos, because clinics and couples fear that the pregnancy rates may decline by using just one embryo.
I think this is going to be a wonderful thing for moving towards single embryo transfer. If you're only going to put back one embryo, its more important than ever that you get the best one, and that is what we think this test can do, Times Online quoted Dr Wells as saying.
The new technique has been used on three women in America and two of them are now pregnant.
The PGS aims to identify chromosomal abnormalities called aneuploidies, which affect up to two thirds of embryos and cause implantation failure or miscarriage.
It is dependent on three new technologies, and comes with improved accuracy and lower risk.
Source: http://www.thaindian.com/newsportal/health/novel-ivf-test-may-cut-risk-of-twins-triplets_10010842.html
For more than a decade, thousands of older women undergoing in-vitro fertilization have relied on an expensive embryo-screening procedure to boost their chances of getting pregnant. But mounting evidence suggests that the procedure doesn’t help people become mothers.
